GSK Pharma begins work to setup Rs 1,000-cr mfg unit

Image
Press Trust of India Mumbai
Last Updated : Sep 08 2015 | 9:22 PM IST
GlaxoSmithKline Pharmaceuticals today began work for setting up a Rs 1,000 crore pharmaceutical manufacturing unit in Karnataka.
Work on GSK India's new Rs 1,000 crore pharmaceutical factory at Vemgal in Karnataka started today as the company restated its commitment to ensuring access to its medicines, a company statement here said.
Karnataka Chief Minister Siddaramaiah laid the foundation
stone in the presence of UK's Minister of State for Trade and Investment Francis Maude.
It will be fully operational in 2017 and will make more than 8 billion tablets and 1 billion capsules for the Indian market. The facility will be built on a 50-acre site in Vemgal, it said.
The facility will also include a warehouse, site infrastructure, employee welfare centre and utilities to support the manufacturing and packing of medicines.
"GSK has been at the forefront of serving the healthcare
needs of India for more than 90 years," company's Managing Director Annaswamy Vaidheesh said.
He added, "We fully support the Government in their efforts to increase access to affordable medicines to improve healthcare and we are very excited to begin work on what will become our largest manufacturing facility in India."
Chief Minister Siddaramaiah said, "GlaxoSmithKline Pharmaceuticals plant in Kolar district is yet another major investment by a multinational company in Karnataka which hopefully, will prompt other companies to come and invest in the State.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 08 2015 | 9:22 PM IST

Next Story